Mineralys Therapeutics, Inc. MLYS Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $24.37M-0.2% | $24.4M-22.4% | $31.45M-17.8% | $38.28M+1.1% | $37.88M-15.0% | ||
| $20.98M+51.1% | $13.88M+43.4% | $9.68M+14.3% | $8.47M+28.9% | $6.57M-8.8% | ||
| $45.34M+18.4% | $38.28M-6.9% | $41.13M-12.0% | $46.75M+5.2% | $44.45M-14.1% | ||
| $45.34M+18.4% | $38.28M-6.9% | $41.13M-12.0% | $46.75M+5.2% | $44.45M-14.1% | ||
| -$45.34M-18.4% | -$38.28M+6.9% | -$41.13M+12.0% | -$46.75M-5.2% | -$44.45M+14.1% | ||
| $6M-0.8% | $6.05M+44.1% | $4.2M+20.8% | $3.47M+55.2% | $2.24M-20.3% | ||
| $6M-0.7% | $6.05M+44.0% | $4.2M+20.9% | $3.47M+55.3% | $2.24M-20.7% | ||
| -$39.34M-22.0% | -$32.23M+12.7% | -$36.93M+14.7% | -$43.27M-2.5% | -$42.21M+13.8% | ||
| -$0.47-34.3% | -$0.35+32.7% | -$0.52+21.2% | -$0.66+16.5% | -$0.79+19.4% | ||
| -$0.47-34.3% | -$0.35+32.7% | -$0.52+21.2% | -$0.66+16.5% | -$0.79+19.4% | ||
| 82.8M+22.4% | 67.7M-4.2% | 70.6M+7.9% | 65.5M+23.1% | 53.2M+9.5% | ||
| 82.8M+22.4% | 67.7M-4.2% | 70.6M+7.9% | 65.5M+23.1% | 53.2M+9.5% | ||
| $6M-0.8% | $6.05M+44.1% | $4.2M+20.8% | $3.47M+55.2% | $2.24M-20.3% | ||
| $5K+400% | $1K-75.0% | $4K+300% | -$2K+33.3% | -$3K-125% | ||
| -$45.34M-18.4% | -$38.28M+6.9% | -$41.13M+12.0% | -$46.75M-5.2% | -$44.45M+14.1% | ||
| -$45.33M-18.5% | -$38.27M+6.9% | -$41.12M+12.0% | -$46.73M-5.2% | -$44.43M+14.1% | ||
| -$45.33M-18.5% | -$38.27M+6.9% | -$41.12M+12.0% | -$46.73M-5.2% | -$44.43M+14.1% | ||
| -$45.34M-18.4% | -$38.28M+6.9% | -$41.13M+12.0% | -$46.75M-5.2% | -$44.45M+14.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Mineralys Therapeutics, Inc.'s income statement data come from?
- Every line is extracted from Mineralys Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.